1100 CAMPUS ROAD, PRINCETON, NJ
News, Material Contracts
Reports First Quarter 2026 Financial Results
Announces Leadership Transition
Integra LifeSciences Enters $150 Million A/R Securitization Facility
Financial Results, Press Release
Integra LifeSciences Adopts Change in Control Severance Program
Reports Third Quarter 2025 Financial Results
Reports Second Quarter 2025 Financial Results
Q1
FY 2024
Q3
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Specialized Disclosure Report